{
    "organizations": [],
    "uuid": "1a1eff5553b9df805bc418dcab651629a5939c94",
    "author": "Jonathan D. Rockoff",
    "url": "https://www.wsj.com/articles/celgene-nears-deal-to-buy-impact-biomedicines-for-as-much-as-7-billion-1515353759",
    "ord_in_thread": 0,
    "title": "Celgene said to be near $7 billion deal to buy Impact Biomedicines - MarketWatch",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Celgene Corp. agreed to buy blood-disease biotechnology company Impact Biomedicines for as much as $7 billion.\nCelgene will make an upfront payment of $1.1 billion for the privately held San Diego company, the companies said in a statement Sunday, confirming an earlier report in The Wall Street Journal.\nAssuming Impact hits regulatory-approval... ",
    "published": "2018-01-07T20:14:00.000+02:00",
    "crawled": "2018-01-08T02:05:53.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "celgene",
        "agreed",
        "buy",
        "biotechnology",
        "company",
        "impact",
        "biomedicine",
        "much",
        "billion",
        "celgene",
        "make",
        "upfront",
        "payment",
        "billion",
        "privately",
        "held",
        "san",
        "diego",
        "company",
        "company",
        "said",
        "statement",
        "sunday",
        "confirming",
        "earlier",
        "report",
        "wall",
        "street",
        "journal",
        "assuming",
        "impact",
        "hit"
    ]
}